Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-22

Clinical Trial Update: Improved Treatment and Monitoring of Alzheimer's Disease [Phase 2]

View source ↗

Summary

This document announces a Phase 2 clinical trial for improved treatment and monitoring of Alzheimer disease that is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Rune Skovgaard Rasmussen | Conditions: Alzheimer Disease (AD) | Phase 2 | Status: NOT_YET_RECRUITING